Add to ORKGforamen ovale closure and brain ischaemic lesions The recently published meta-analysis by Wolfrum et al assessed the ability of percu-taneous closure of patent foramen ovale (PFO) to reduce the incidence of recurrent stroke based on three randomised con-trolled clinical trials (RCT). This analysis did not demonstrate a superiority of the closure of PFO compared with medical therapy after 2–4 years of follow-up in patients with cryptogenic embolism.1 The closure was associated with lower, albeit nonsignificant, incidence of nonfatal stroke. The relatively low incidence o
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
BACKGROUND Up to 40% of ischaemic strokes are cryptogenic. A strong association between cryptogen...
foramen ovale closure and brain ischaemic lesions To the Editor The recently published meta-analysis...
About one-third of ischemic stroke are cryptogenic. Paradoxical embolism through patent foramen oval...
BACKGROUND: The clinical benefit of patent foramen ovale (PFO) closure after cryptogenic stroke has ...
Approximately 40% of patients with cryptogenic stroke have a Permeable Foramen Oval, which is presen...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
Patent foramen ovale (PFO) is a common benign finding in healthy subjects, but its prevalence is hig...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and pate...
For patients with cryptogenic stroke found to have a patentforamen ovale (PFO), the rationale for me...
Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved saf...
Up to a third of strokes are cryptogenic. The prevalence of patent foramen ovale (PFO) in patients w...
© Springer-Verlag GmbH Germany, part of Springer Nature 2018A patent foramen ovale (PFO) is a highly...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
BACKGROUND Up to 40% of ischaemic strokes are cryptogenic. A strong association between cryptogen...
foramen ovale closure and brain ischaemic lesions To the Editor The recently published meta-analysis...
About one-third of ischemic stroke are cryptogenic. Paradoxical embolism through patent foramen oval...
BACKGROUND: The clinical benefit of patent foramen ovale (PFO) closure after cryptogenic stroke has ...
Approximately 40% of patients with cryptogenic stroke have a Permeable Foramen Oval, which is presen...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
Patent foramen ovale (PFO) is a common benign finding in healthy subjects, but its prevalence is hig...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and pate...
For patients with cryptogenic stroke found to have a patentforamen ovale (PFO), the rationale for me...
Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved saf...
Up to a third of strokes are cryptogenic. The prevalence of patent foramen ovale (PFO) in patients w...
© Springer-Verlag GmbH Germany, part of Springer Nature 2018A patent foramen ovale (PFO) is a highly...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
BACKGROUND Up to 40% of ischaemic strokes are cryptogenic. A strong association between cryptogen...